Claims
- 1. An isolated segment of DNA which codes for a protein having the amino acid sequence of the GA733-1 antigen.
- 2. The segment of DNA of claim 1 having the nucleic acid sequence shown in FIG. 2.
- 3. A cell line genetically engineered to replicate and express a DNA sequence which codes for a protein having the amino acid sequence of the GA733-1 antigen.
- 4. A method of producing a protein which has the amino acid sequence of the GA733-1 antigen comprising:
- culturing cells in a culture medium, which cells have been genetically engineered to replicate and express a DNA sequence which codes for a protein which has the amino acid sequence of the GA733-1 antigen;
- harvesting said protein from said cells or culture medium.
BACKGROUND OF THE INVENTION
The U.S. government has a paid-up license in this invention and the right in limited circumstances to require the patent owner to license others on reasonable terms as provided for by the terms of Grant No. CA 21124-11 from the National Institutes of Health.
Non-Patent Literature Citations (3)
Entry |
Beauchemin et al Mol Cell Biol 7(9):3221, 1987. |
Ross et al Biochem Biophys Res. Comm. 135:297, 1986. |
Proc. Natl. Acad. Sci. USA, vol. 87, pp. 3542-3546, dated May 1990 Entitled: "Molecular cloning of cDNA for the carcinoma-associated antigen GA733-2", by Stanislaw Szala, et al. |